In general, MT1 seems to play a prominent role in triggering anti-tumor cellular responses mediated by melatonin [53,54,55,154,155,156,157,158,159], although in some experimental models MT2 has been shown to be required too [160,161]. This evidence concerns the gene MTNR1A and neoplasm.